Juve's Llorente set for Sevilla medical
Juventus striker Fernando Llorente is set to join Europa League winners Sevilla with teammate Mauricio Isla also on his way to the Spanish club, it was announced on Wednesday. Juventus signed Llorente -- scorer of seven goals in 24 appearances for Spain and a member of the 2010 World Cup and Euro 2012 winning sides -- on a free transfer from Athletic Bilbao two years ago but the towering striker is now surplus to requirements in Turin and Juve have decided to cash in with Sevilla confirming the deal on Wednesday. "Fernando Llorente is coming to Seville tonight with permission from his club, Juventus, to have a medical in the next few hours with Sevilla FC", said the La Liga side. Gazzetta dello Sport's website had earlier said the Italian champions will recoup 7m euros ($10m) plus performance-related bonuses for the 30-year-old Spaniard, who will sign a permanent deal with Unai Emery's side and fill the gap left by the departure of Colombian international Carlos Bacca to AC Milan. Chilean international midfielder Isla, who last season went on loan to Queens Park Rangers, is also reported to be part of the deal. Juventus have seen key changes among personnel in the wake of losing the Champions League final to Barcelona last May. Striker Carlos Tevez (Boca Juniors) and midfielders Arturo Vidal (Bayern Munich), Andrea Pirlo (New York City FC) and Simone Pepe (Chievo) were among the several players who left the club. But the Old Lady have filled the gaps, and arguably have an excess of strikers with Mario Mandzukic (Atletico Madrid) and Paulo Dybala (Palermo) joining this summer, with Spanish international Alvaro Morata and French youngster Kingsley Coman already on their books. Coach Massimiliano Allegri welcomed a total of seven new faces in the close season, including Germany international midfielder Sami Khedira (Real Madrid), Brazilian defender Alex Sandro (FC Porto) and Chelsea forward Juan Cuadrado, who sealed a season-long loan move from the English champions on Tuesday.
